IP Verse

Novel Pharmaceutical Composition

PatentPatent Analysis

EP4159204

NOVARTIS
Application Number
EP22209104A
Filing Date
Dec 20, 2011
Status
Granted And Under Opposition
Jan 12, 2024
Grant Date
Feb 14, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Biblio Summary

The patent EP4159204B1 was granted to Novartis on Feb 14, 2024 following the initial filing on Dec 20, 2011 under the application number EP22209104A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLERNov 14, 2024ADMISSIBLE
GENERICS UKNov 14, 2024ADMISSIBLE
TEVA PHARMACEUTICALSNov 13, 2024ADMISSIBLE
HAMM & WITTKOPPNov 11, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents